Koninklijke Philips (PHG) Cash from Investing Activities Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -50.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -187.82% |
| Dec 31, 2025 | -40.11% |
| Sep 30, 2025 | -21.50% |
| Jun 30, 2025 | -146.34% |
| Mar 31, 2025 | 13.13% |
| Dec 31, 2024 | 10.52% |
| Jun 30, 2024 | 55.10% |
| Dec 31, 2023 | 54.89% |
| Jun 30, 2023 | 58.23% |
| Dec 31, 2022 | 63.88% |
| Jun 30, 2022 | 75.77% |
| Dec 31, 2021 | -178.07% |
| Jun 30, 2021 | -542.19% |
| Dec 31, 2020 | -126.33% |
| Jun 30, 2020 | -14.61% |
| Dec 31, 2019 | 60.65% |
| Jun 30, 2019 | 29.42% |
| Dec 31, 2018 | 54.97% |
| Jun 30, 2018 | -79.84% |
| Dec 31, 2017 | -219.46% |
| Sep 30, 2017 | -1,185.06% |
| Jun 30, 2017 | 25.93% |
| Dec 31, 2016 | 44.58% |
| Sep 30, 2016 | 89.59% |
| Jun 30, 2016 | 66.49% |
| Mar 31, 2016 | 78.17% |
| Dec 31, 2015 | -73.00% |
| Jun 30, 2013 | -34.08% |
| Mar 31, 2013 | -93.21% |
| Dec 31, 2012 | 31.16% |
| Sep 30, 2012 | 35.83% |
| Jun 30, 2012 | 42.67% |
| Mar 31, 2012 | 20.72% |
| Dec 31, 2011 | -366.63% |
| Sep 30, 2011 | -1,602.14% |
| Jun 30, 2011 | -85.81% |
| Mar 31, 2011 | -110.45% |
| Dec 31, 2010 | -15.47% |